Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,960.00
-90.00 (-0.90%)
At close: Aug 3, 2026

Whan In Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
15,94113,59523,38129,77423,92126,660
Depreciation & Amortization
9,8519,8658,4756,6594,8474,202
Loss (Gain) From Sale of Assets
267.38281.59330.111,1601,8976.22
Loss (Gain) From Sale of Investments
---392.98-1,168849.94-352.07
Loss (Gain) on Equity Investments
225.9199.72-1,9811,006201.0861.86
Provision & Write-off of Bad Debts
1,5251,6931,396874.841,0661,094
Other Operating Activities
370.25631.785,667714.37-3,124-229.16
Change in Accounts Receivable
354.957,4501,088-7,320-10,221-56.46
Change in Inventory
-19,108-24,239-22,546-17,631-3,89311.94
Change in Accounts Payable
-3,246458.444,8669,2552,4093,555
Change in Other Net Operating Assets
-105.09-892.06411.23-128.37-1,102365.9
Operating Cash Flow
6,0789,04420,69323,19716,85135,318
Operating Cash Flow Growth
-71.18%-56.30%-10.79%37.66%-52.29%55.21%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,165-2,850-27,357-30,531-33,650-4,387
Sale of Property, Plant & Equipment
0.550.553.9588.7480.4434.75
Sale (Purchase) of Intangibles
-3,039-3,332-2,024-941.14-642.7-374.92
Sale (Purchase) of Real Estate
---153.69-33,466-
Investment in Securities
4,60910,98611,32121,77529,4892,409
Other Investing Activities
84.49-80.51-5858.41-779.69222.53
Investing Cash Flow
-487.024,747-18,095-9,432-38,942-2,122

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--539.92-465.53-414.47-549.98-613.78
Net Debt Issued (Repaid)
-538.57-539.92-465.53-414.47-549.98-613.78
Issuance of Common Stock
11,39611,396----
Dividends Paid
-4,580-4,580-4,580-4,580-4,580-4,580
Other Financing Activities
135307.91-4.95-171.43--
Financing Cash Flow
6,4126,584-5,051-5,166-5,130-5,194

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
104.2758.17233.66-8.58-59.27-19.77
Net Cash Flow
12,10720,433-2,2198,591-27,28027,982

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,9126,194-6,664-7,334-16,79930,931
Free Cash Flow Growth
30.57%----109.47%
Free Cash Flow Margin
1.47%2.43%-2.57%-3.18%-8.44%17.40%
Free Cash Flow Per Share
234.84390.61-436.48-480.39-1100.322025.98
Levered Free Cash Flow
9,7389,973-20,163-21,346-23,44624,210
Unlevered Free Cash Flow
9,7579,991-20,148-21,332-23,41424,242

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
31.128.7723.1222.6651.8851.55
Cash Income Tax Paid
6,9215,1795,0945,0098,3548,107
Change in Working Capital
-22,104-17,223-16,181-15,824-12,8073,876